These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


354 related items for PubMed ID: 22652070

  • 1. Gene expression profile of human peripheral blood mononuclear cells induced by Staphylococcus aureus lipoteichoic acid.
    Kang SS, Kim HJ, Jang MS, Moon S, In Lee S, Jeon JH, Baik JE, Park OJ, Son YM, Kim GR, Joo D, Kim H, Han JY, Yun CH, Han SH.
    Int Immunopharmacol; 2012 Aug; 13(4):454-60. PubMed ID: 22652070
    [Abstract] [Full Text] [Related]

  • 2. Gene expression profiling of bovine mammary gland epithelial cells stimulated with lipoteichoic acid plus peptidoglycan from Staphylococcus aureus.
    Im J, Lee T, Jeon JH, Baik JE, Kim KW, Kang SS, Yun CH, Kim H, Han SH.
    Int Immunopharmacol; 2014 Jul; 21(1):231-40. PubMed ID: 24836680
    [Abstract] [Full Text] [Related]

  • 3. Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW 264.7 macrophages: modulation by A2A and A2B adenosine receptors.
    Souza LF, Jardim FR, Sauter IP, Souza MM, Barreto F, Margis R, Bernard EA.
    Mol Immunol; 2009 Feb; 46(5):937-42. PubMed ID: 18950865
    [Abstract] [Full Text] [Related]

  • 4. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C, Espevik T, Golenbock D, Foster D, Solberg R, Aasen A, Wang J.
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [Abstract] [Full Text] [Related]

  • 5. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
    Kinsner A, Boveri M, Hareng L, Brown GC, Coecke S, Hartung T, Bal-Price A.
    J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
    [Abstract] [Full Text] [Related]

  • 6. Lipoteichoic acid of Staphylococcus aureus enhances IL-6 expression in activated human basophils.
    Jeon JH, Kim SK, Baik JE, Kang SS, Yun CH, Chung DK, Han SH.
    Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):363-74. PubMed ID: 22445541
    [Abstract] [Full Text] [Related]

  • 7. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans.
    Hoogerwerf JJ, de Vos AF, Bresser P, van der Zee JS, Pater JM, de Boer A, Tanck M, Lundell DL, Her-Jenh C, Draing C, von Aulock S, van der Poll T.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):34-41. PubMed ID: 18403723
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of tammar (Macropus eugenii) mammary epithelial cells stimulated with lipopolysaccharide and lipoteichoic acid.
    Daly KA, Mailer SL, Digby MR, Lefévre C, Thomson P, Deane E, Nicholas KR, Williamson P.
    Vet Immunol Immunopathol; 2009 May 15; 129(1-2):36-48. PubMed ID: 19157568
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.
    Han SH, Kim JH, Martin M, Michalek SM, Nahm MH.
    Infect Immun; 2003 Oct 15; 71(10):5541-8. PubMed ID: 14500472
    [Abstract] [Full Text] [Related]

  • 10. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.
    Hattar K, Grandel U, Moeller A, Fink L, Iglhaut J, Hartung T, Morath S, Seeger W, Grimminger F, Sibelius U.
    Crit Care Med; 2006 Mar 15; 34(3):835-41. PubMed ID: 16521278
    [Abstract] [Full Text] [Related]

  • 11. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment.
    von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KP, van Strijp JA, Hartung T.
    Immunobiology; 2003 Mar 15; 208(4):413-22. PubMed ID: 14748514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance.
    Schmidt RR, Pedersen CM, Qiao Y, Zähringer U.
    Org Biomol Chem; 2011 Apr 07; 9(7):2040-52. PubMed ID: 21327200
    [Abstract] [Full Text] [Related]

  • 16. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells.
    Blease K, Chen Y, Hellewell PG, Burke-Gaffney A.
    J Immunol; 1999 Dec 01; 163(11):6139-47. PubMed ID: 10570304
    [Abstract] [Full Text] [Related]

  • 17. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
    Yang J, Ryu YH, Yun CH, Han SH.
    J Leukoc Biol; 2009 Oct 01; 86(4):823-31. PubMed ID: 19602669
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages.
    Wu BQ, Luo JM, Wang YH, Shi YF, Liu H, Ba JH, Zhang TT.
    Clin Exp Med; 2014 May 01; 14(2):151-60. PubMed ID: 23456570
    [Abstract] [Full Text] [Related]

  • 19. Presentation of lipoteichoic acid potentiates its inflammatory activity.
    Deininger S, Traub S, Aichele D, Rupp T, Baris T, Möller HM, Hartung T, von Aulock S.
    Immunobiology; 2008 May 01; 213(6):519-29. PubMed ID: 18514754
    [Abstract] [Full Text] [Related]

  • 20. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids.
    Ryu YH, Baik JE, Yang JS, Kang SS, Im J, Yun CH, Kim DW, Lee K, Chung DK, Ju HR, Han SH.
    Int Immunopharmacol; 2009 Jan 01; 9(1):127-33. PubMed ID: 19013542
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.